Literature DB >> 15542702

Specific gene expression and possible involvement of inflammation in methamphetamine-induced neurotoxicity.

Masato Asanuma1, Ikuko Miyazaki, Youichirou Higashi, Takeshi Tsuji, Norio Ogawa.   

Abstract

To reveal specific gene expression in methamphetamine (METH) -induced dopamine neurotoxicity, temporal characteristics of METH-induced changes in gene expression in dopaminergic neuronal cells were examined using the cDNA array and the differential display method. A number of genes in the class of "trafficking & protein turnover," "metabolic pathways," "transmitters & receptors," and "growth factors, cytokines" were upregulated after the METH treatment in the cDNA array assay. Whereas, some genes related to trafficking & protein turnover and "modulators, effectors & intracellular transducers" were decreased by METH. Some proteins associated with synaptic vesicle transportation indeed up- or downregulated after the METH treatment. These data suggest that the protein trafficking and degradation system is involved in the dopaminergic cell death induced by METH. Furthermore, focusing on inflammatory reactions after METH injection, possible neuroprotective property of nonsteroidal anti-inflammatory drugs were examined against METH-induced neurotoxicity. Coadministration of NSAID with METH significantly attenuated striatal dopamine terminal degeneration and microgliosis induced by METH, suggesting that the protective effects are based on their inhibitory activity on production of cytokines and nitric oxides or their suppressive action against microglia activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542702     DOI: 10.1196/annals.1316.009

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  27 in total

1.  Suppression of endogenous PPARγ increases vulnerability to methamphetamine-induced injury in mouse nigrostriatal dopaminergic pathway.

Authors:  Seong-Jin Yu; Mikko Airavaara; Hui Shen; Jenny Chou; Brandon K Harvey; Yun Wang
Journal:  Psychopharmacology (Berl)       Date:  2011-12-13       Impact factor: 4.530

Review 2.  Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection.

Authors:  Kenneth H Clark; Clayton A Wiley; Charles W Bradberry
Journal:  Neurotox Res       Date:  2012-06-20       Impact factor: 3.911

Review 3.  Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways.

Authors:  Irina N Krasnova; Zuzana Justinova; Jean Lud Cadet
Journal:  Psychopharmacology (Berl)       Date:  2016-02-12       Impact factor: 4.530

4.  Dual role of PPAR-γ in induction and expression of behavioral sensitization to cannabinoid receptor agonist WIN55,212-2.

Authors:  Leili Enayatfard; Farzaneh Rostami; Sanaz Nasoohi; Shahrbanoo Oryan; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Neuromolecular Med       Date:  2013-06-21       Impact factor: 3.843

5.  Cocaine-Mediated Downregulation of miR-124 Activates Microglia by Targeting KLF4 and TLR4 Signaling.

Authors:  Palsamy Periyasamy; Ke Liao; Yeon Hee Kook; Fang Niu; Shannon E Callen; Ming-Lei Guo; Shilpa Buch
Journal:  Mol Neurobiol       Date:  2017-05-06       Impact factor: 5.590

6.  Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine.

Authors:  Angelica M Morales; Buyean Lee; Gerhard Hellemann; Joseph O'Neill; Edythe D London
Journal:  Drug Alcohol Depend       Date:  2012-03-22       Impact factor: 4.492

7.  Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis.

Authors:  Supriya D Mahajan; Zihua Hu; Jessica L Reynolds; Ravikumar Aalinkeel; Stanley A Schwartz; Madhavan P N Nair
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

8.  Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.

Authors:  Sarah E A McConnell; M Kerry O'Banion; Deborah A Cory-Slechta; John A Olschowka; Lisa A Opanashuk
Journal:  Neurotoxicology       Date:  2015-08-15       Impact factor: 4.294

9.  Drugs of abuse that mediate advanced glycation end product formation: a chemical link to disease pathology.

Authors:  Jennifer B Treweek; Tobin J Dickerson; Kim D Janda
Journal:  Acc Chem Res       Date:  2009-05-19       Impact factor: 22.384

Review 10.  Neuroimmune basis of methamphetamine toxicity.

Authors:  Jennifer M Loftis; Aaron Janowsky
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.